Skip to main content
. 2023 Dec 23;25(1):251. doi: 10.3390/ijms25010251

Figure 5.

Figure 5

Apigenin (APG) inhibits metastasis and angiogenesis by modulating signaling pathways (MAPK, Akt, NF-κB) and the expression of their target genes (MMPs, snail, twist, β-catenin) associated with epithelial–mesenchymal transition [1]. Furthermore, APG downregulates HiF-1α and VEGF/VEGFR in the tumor environment.